Literature DB >> 29707342

Aortic arch repair under moderate hypothermic circulatory arrest with or without antegrade cerebral perfusion based on the extent of repair.

Sung Jun Park1, Bo Bae Jeon2, Hee Jung Kim3, Joon Bum Kim2.   

Abstract

BACKGROUND: For aortic-arch repair, moderate hypothermic circulatory arrest (HCA) have shown favorable outcomes over conventional deep HCA when coupled with antegrade cerebral perfusion (ACP); however, recent studies have shown that ACP may not be essential when circulatory arrest time is less than 30 minutes. This study aims to evaluate the stratified arch repair strategy of moderate HCA with or without ACP based on the extent of procedure.
METHODS: Consecutive 138 patients (63 female; mean age, 60.2±15.7 years) undergoing open arch repair due to acute aortic syndrome (n=69) or chronic aneurysm (n=69) from January 2012 through April 2017 were enrolled in this study. Stratified neuroprotective strategy was employed according to the extent of repair: hemi-arch repair (n=93) was performed under moderated HCA alone and total-arch repair (n=45) under moderate HCA combined with unilateral ACP.
RESULTS: Median total circulatory arrest and total procedural times were 8.0 minutes [interquartile range (IQR), 6.0-10.0] and 233.0 minutes (IQR, 196.0-290.0 minutes), respectively in the hemi-arch group, and 25.0 minutes (IQR, 12.0-33.0 minutes) and 349.0 minutes (IQR, 276.0-406.0 minutes), respectively in the total-arch group. Early mortality occurred in 2 patients (1.4%) who underwent hemi-arch repair for acute aortic dissection. There was no permanent neurological injury, but 2 cases (1.4%) of temporary neurologic deficit in the hemi-arch group. Other complications included re-exploration for bleeding in 6 (4.3%), postoperative extracorporeal life support in 5 (3.6%) and new-dialysis in 6 (4.3%).
CONCLUSIONS: Stratified cerebral perfusion strategy using moderate hypothermia for aortic-arch surgery based on the extent of arch repair showed satisfactory safety and reasonable efficiency.

Entities:  

Keywords:  Aortic arch surgery; cerebral protection; circulatory arrest; hypothermia

Year:  2018        PMID: 29707342      PMCID: PMC5906280          DOI: 10.21037/jtd.2018.03.51

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  17 in total

1.  Arterial cannulation of the innominate artery.

Authors:  M K Banbury; D M Cosgrove
Journal:  Ann Thorac Surg       Date:  2000-03       Impact factor: 4.330

2.  Cerebral protection during surgery for acute aortic dissection type A: results of the German Registry for Acute Aortic Dissection Type A (GERAADA).

Authors:  Tobias Krüger; Ernst Weigang; Isabell Hoffmann; Maria Blettner; Hermann Aebert
Journal:  Circulation       Date:  2011-07-11       Impact factor: 29.690

3.  Ascending aortic cannulation in acute type a dissection repair.

Authors:  John R Frederick; Elaine Yang; Alen Trubelja; Nimesh D Desai; Wilson Y Szeto; Alberto Pochettino; Joseph E Bavaria; Y Joseph Woo
Journal:  Ann Thorac Surg       Date:  2013-05       Impact factor: 4.330

4.  Mild-to-moderate hypothermia in aortic arch surgery using circulatory arrest: a change of paradigm?

Authors:  Paul P Urbanski; Aristidis Lenos; Petros Bougioukakis; Ioannis Neophytou; Michael Zacher; Anno Diegeler
Journal:  Eur J Cardiothorac Surg       Date:  2012-01       Impact factor: 4.191

Review 5.  Unilateral versus bilateral antegrade cerebral protection during circulatory arrest in aortic surgery: a meta-analysis of 5100 patients.

Authors:  Emiliano Angeloni; Umberto Benedetto; Johanna J M Takkenberg; Ivan Stigliano; Antonino Roscitano; Giovanni Melina; Riccardo Sinatra
Journal:  J Thorac Cardiovasc Surg       Date:  2012-11-09       Impact factor: 5.209

6.  A study of brain protection during total arch replacement comparing antegrade cerebral perfusion versus hypothermic circulatory arrest, with or without retrograde cerebral perfusion: analysis based on the Japan Adult Cardiovascular Surgery Database.

Authors:  Yutaka Okita; Hiroaki Miyata; Noboru Motomura; Shinichi Takamoto
Journal:  J Thorac Cardiovasc Surg       Date:  2014-09-21       Impact factor: 5.209

7.  Total arch repair versus hemiarch repair in the management of acute DeBakey type I aortic dissection.

Authors:  Joon Bum Kim; Cheol Hyun Chung; Duk Hwan Moon; Geong Jun Ha; Taek Yeon Lee; Sung Ho Jung; Suk Jung Choo; Jae Won Lee
Journal:  Eur J Cardiothorac Surg       Date:  2011-02-18       Impact factor: 4.191

8.  Does moderate hypothermia really carry less bleeding risk than deep hypothermia for circulatory arrest? A propensity-matched comparison in hemiarch replacement.

Authors:  Jeffrey E Keenan; Hanghang Wang; Brian C Gulack; Asvin M Ganapathi; Nicholas D Andersen; Brian R Englum; Yamini Krishnamurthy; Jerrold H Levy; Ian J Welsby; G Chad Hughes
Journal:  J Thorac Cardiovasc Surg       Date:  2016-08-28       Impact factor: 5.209

9.  Comparison of ascending aorta versus femoral artery cannulation for acute aortic dissection type A.

Authors:  Hiroyuki Kamiya; Klaus Kallenbach; Dominique Halmer; Merve Ozsöz; Kathrin Ilg; Artur Lichtenberg; Matthias Karck
Journal:  Circulation       Date:  2009-09-15       Impact factor: 29.690

Review 10.  Does the arterial cannulation site for circulatory arrest influence stroke risk?

Authors:  Lars G Svensson; Eugene H Blackstone; Jeevanantham Rajeswaran; Joseph F Sabik; Bruce W Lytle; Gonzalo Gonzalez-Stawinski; Poseidon Varvitsiotis; Michael K Banbury; Patrick M McCarthy; Gösta B Pettersson; Delos M Cosgrove
Journal:  Ann Thorac Surg       Date:  2004-10       Impact factor: 4.330

View more
  2 in total

1.  Mini-access open arch repair.

Authors:  Shi A Kim; Won Kyung Pyo; You Jung Ok; Ho Jin Kim; Joon Bum Kim
Journal:  J Thorac Dis       Date:  2021-04       Impact factor: 2.895

2.  "Aorta-clamp" technique for surgical repair of acute type A aortic dissection-5 min circulatory arrest at 30 °C.

Authors:  Jie He; Jihai Peng; Wei Li; Dingwen Zheng; Shihao Cai; Wenliu Xu; Jinsong Huang; Xiaoping Fan
Journal:  J Thorac Dis       Date:  2019-11       Impact factor: 2.895

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.